Advertisement

Topics

BMS partners antiviral candidates with CN Bio Innovations

15:40 EDT 22 May 2017 | Elsevier Business Intelligence

CN Bio Innovations Ltd. received exclusive worldwide rights to Bristol-Myers Squibb Co.'s discovery-stage small-molecule anti...

Original Article: BMS partners antiviral candidates with CN Bio Innovations

NEXT ARTICLE

More From BioPortfolio on "BMS partners antiviral candidates with CN Bio Innovations"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...